Research statistics

Angiotensin (1-7) Analog research: publications and trials

What has been published on Angiotensin (1-7) Analog: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Angiotensin (1-7) Analog works or is safe. For what it is and what the studies found, see the Angiotensin (1-7) Analog profile.
Automated weekly refresh · data through November 15, 2026

At a glance

Publications, all years

88

Since 2002

Publications in 2026 so far

4

Through November 15, 2026

Human clinical research

0.0%

0 of 88 classified

Registered clinical trials

0

ClinicalTrials.gov

Randomized controlled trials

0

Publications reporting an RCT in people

Systematic reviews and meta-analyses

0

Preclinical studies

92.0%

70 animal · 11 in vitro · 0 computational

Records that only mention it

6

Not counted above

Status in the library: Research only.

What to keep in mind

  • No human clinical publication is indexed: everything published so far is preclinical, a review or commentary.
  • Fewer than three randomized controlled trials are indexed.
  • More than 70% of the indexed publications are animal, cell or computational studies.

Publications by year

Angiotensin (1-7) Analog publications by year and evidence

2002, Preclinical (animal, in vitro, computational): 1 of 12003, Other and not yet classified: 1 of 12004, Preclinical (animal, in vitro, computational): 1 of 12005, Preclinical (animal, in vitro, computational): 2 of 32005, Reviews and meta-analyses: 1 of 32006, Preclinical (animal, in vitro, computational): 2 of 32006, Reviews and meta-analyses: 1 of 32007, Preclinical (animal, in vitro, computational): 4 of 42008, Preclinical (animal, in vitro, computational): 1 of 12009, Preclinical (animal, in vitro, computational): 1 of 12010, Preclinical (animal, in vitro, computational): 5 of 52011, Preclinical (animal, in vitro, computational): 1 of 12012, Preclinical (animal, in vitro, computational): 8 of 82013, Preclinical (animal, in vitro, computational): 7 of 72014, Preclinical (animal, in vitro, computational): 1 of 12015, Preclinical (animal, in vitro, computational): 3 of 32016, Preclinical (animal, in vitro, computational): 2 of 22017, Preclinical (animal, in vitro, computational): 1 of 12018, Preclinical (animal, in vitro, computational): 3 of 32019, Preclinical (animal, in vitro, computational): 6 of 62020, Preclinical (animal, in vitro, computational): 6 of 72020, Reviews and meta-analyses: 1 of 72021, Preclinical (animal, in vitro, computational): 8 of 92021, Other and not yet classified: 1 of 92022, Preclinical (animal, in vitro, computational): 3 of 42022, Reviews and meta-analyses: 1 of 42023, Preclinical (animal, in vitro, computational): 3 of 32024, Preclinical (animal, in vitro, computational): 3 of 42024, Reviews and meta-analyses: 1 of 42025, Preclinical (animal, in vitro, computational): 5 of 52026 (to date), Preclinical (animal, in vitro, computational): 4 of 4Preclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified0510200220072012201720222026*
Counted PubMed publications by year of first publication. * 2026 runs to November 15, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
20021001
20030011
20041001
20052103
20062103
20074004
20081001
20091001
20105005
20111001
20128008
20137007
20141001
20153003
20162002
20171001
20183003
20196006
20206107
20218019
20223104
20233003
20243104
20255005
2026 (to date)4004

Study types

Animal study70
In vitro study11
Review5
Editorial, letter or other2

Research areas

From MeSH major topics. A paper can be in several areas.

Cardiovascular58
Immune system17
Neurological and mental health16
Tissue repair11
Gastrointestinal10
Metabolic health7
Endocrinology6
Reproductive and sexual health6
Cognitive health5
Antimicrobial and infectious disease4
Oncology4
Obesity and weight management3

Registered clinical trials

A registration is not a result.

No registered trials.

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

No human trial, systematic review or meta-analysis of Angiotensin (1-7) Analog is indexed.

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium.

    Hypertension (Dallas, Tex. : 1979) · December 1, 2002 · In vitro study · cited 199 times

    PMID 12468568 · DOI 10.1161/01.hyp.0000037979.53963.8f · In vitro studies

  2. Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.

    American journal of physiology. Heart and circulatory physiology · February 1, 2006 · Animal study · cited 187 times

    PMID 16403946 · DOI 10.1152/ajpheart.00632.2005 · Animal studies

  3. Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis.

    Journal of immunology (Baltimore, Md. : 1950) · October 8, 2010 · Animal study · cited 182 times

    PMID 20935211 · DOI 10.4049/jimmunol.1000314 · Animal studies

  4. Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney.

    Hypertension (Dallas, Tex. : 1979) · August 23, 2004 · Animal study · cited 175 times · open access

    PMID 15326087 · DOI 10.1161/01.hyp.0000141438.64887.42 · Animal studies

  5. AVE 0991 attenuates oxidative stress and neuronal apoptosis via Mas/PKA/CREB/UCP-2 pathway after subarachnoid hemorrhage in rats.

    Redox biology · September 28, 2018 · Animal study · cited 174 times · open access

    PMID 30296700 · DOI 10.1016/j.redox.2018.09.022 · Animal studies

Latest publications

  1. Cross talk between SARS-CoV-2 and the angiotensin system: clinical implications.

    American journal of physiology. Cell physiology · September 2, 2026 · In vitro study · cited 0 times

    PMID 42684673 · DOI 10.1152/ajpcell.00786.2025 · In vitro studies

  2. Mas receptor activation promotes mitophagy and preserves neuronal function after traumatic brain injury.

    Mitochondrion · August 6, 2026 · Animal study · cited 0 times

    PMID 42562073 · DOI 10.1016/j.mito.2026.102200 · Animal studies

  3. The nonpeptide angiotensin-(1-7) mimic AVE0991 attenuates neuroendocrine and behavioral responses to chronic unpredictable stress.

    Psychopharmacology · July 13, 2026 · Animal study · cited 0 times · open access

    PMID 42440117 · DOI 10.1007/s00213-026-07126-4 · Animal studies

  4. Mas receptor activation regulates the functional phenotype of myocardial macrophages through the Akt/Nrf2 signaling pathway to alleviate sepsis-induced cardiomyopathy.

    Journal of translational medicine · April 24, 2026 · Animal study · cited 1 times · open access

    PMID 42032737 · DOI 10.1186/s12967-026-08171-5 · Animal studies

  5. Blood pressure reduction and anti-inflammatory macrophage augmentation attenuate uterine immune dysregulation and inflammation in mice with salt-sensitive hypertension.

    Clinical science (London, England : 1979) · December 1, 2025 · Animal study · cited 0 times · open access

    PMID 41055571 · DOI 10.1042/cs20255879 · Animal studies

  6. Role of G-protein-coupled receptor kinase 4 on the dysfunction of renal Mas receptor in hypertension.

    PloS one · August 5, 2025 · Animal study · cited 0 times · open access

    PMID 40763158 · DOI 10.1371/journal.pone.0329547 · Animal studies

  7. The Non-Peptide MAS-R Agonist AVE0991 Alleviates Colitis Severity in Mice and Exhibits an Additive Effect with Azathioprine.

    International journal of molecular sciences · June 17, 2025 · Animal study · cited 0 times · open access

    PMID 40565247 · DOI 10.3390/ijms26125784 · Animal studies

  8. Activation of central Angiotensin-(1-7)/Mas receptor alleviates synaptic damage in diabetes-associated cognitive impairment via modulating AKT/FOXO1/PACAP axis.

    International journal of biological sciences · April 9, 2025 · Animal study · cited 8 times · open access

    PMID 40303297 · DOI 10.7150/ijbs.99617 · Animal studies

  9. Angiotensin 1-7 and the Non-Peptide MAS-R Agonist AVE0991 Inhibit Breast Cancer Cell Migration and Invasion.

    Biomedicines · February 24, 2025 · In vitro study · cited 1 times · open access

    PMID 40149544 · DOI 10.3390/biomedicines13030567 · In vitro studies

  10. AVE0991 ameliorates dopaminergic neuronal damage in Parkinson's disease through HOTAIRM1/miR-223-3p/α-synuclein axis.

    Scientific reports · November 1, 2024 · Animal study · cited 5 times · open access

    PMID 39487232 · DOI 10.1038/s41598-024-76058-w · Animal studies

Browse all 88 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: AVE0991

((TITLE_ABS:"AVE0991" OR CHEM:"AVE0991" OR TITLE_ABS:"AVE 0991" OR CHEM:"AVE 0991")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 16). Angiotensin (1-7) Analog research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/ang-1-7-analog